These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 32706289)
1. Adjudin-loaded redox-sensitive paclitaxel-prodrug micelles for overcoming multidrug resistance with efficient targeted Colon cancer therapy. Chen D; Ge S; Zuo L; Wang S; Liu M; Li S Drug Deliv; 2020 Dec; 27(1):1094-1105. PubMed ID: 32706289 [TBL] [Abstract][Full Text] [Related]
2. A simple reduction-sensitive micelles co-delivery of paclitaxel and dasatinib to overcome tumor multidrug resistance. Li J; Xu R; Lu X; He J; Jin S Int J Nanomedicine; 2017; 12():8043-8056. PubMed ID: 29138561 [TBL] [Abstract][Full Text] [Related]
3. pH-triggered surface charge-switchable polymer micelles for the co-delivery of paclitaxel/disulfiram and overcoming multidrug resistance in cancer. Huo Q; Zhu J; Niu Y; Shi H; Gong Y; Li Y; Song H; Liu Y Int J Nanomedicine; 2017; 12():8631-8647. PubMed ID: 29270012 [TBL] [Abstract][Full Text] [Related]
4. A convenient protonated strategy for constructing nanodrugs from hydrophobic drug-inhibitor conjugates to reverse tumor multidrug resistance. Wang P; Wang Y; Xia X; Wu J; Lin J; Huang W; Yan D Nanoscale; 2024 May; 16(17):8434-8446. PubMed ID: 38592819 [TBL] [Abstract][Full Text] [Related]
5. LHRH-Targeted Redox-Responsive Crosslinked Micelles Impart Selective Drug Delivery and Effective Chemotherapy in Triple-Negative Breast Cancer. Xiao K; Liu Q; Suby N; Xiao W; Agrawal R; Vu M; Zhang H; Luo Y; Li Y; Lam KS Adv Healthc Mater; 2021 Feb; 10(3):e2001196. PubMed ID: 33200571 [TBL] [Abstract][Full Text] [Related]
6. Novel GSH-responsive prodrugs derived from indole-chalcone and camptothecin trigger apoptosis and autophagy in colon cancer. Wang H; Nie C; Luo M; Bai Q; Yao Z; Lv H; Chen B; Wang J; Xu W; Wang S; Chen X Bioorg Chem; 2024 Feb; 143():107056. PubMed ID: 38183685 [TBL] [Abstract][Full Text] [Related]
7. A Co-delivery System Based on a Dimeric Prodrug and Star-Shaped Polymeric Prodrug Micelles for Drug Delivery. Zhou M; Luo Y; Zeng W; Yang X; Chen T; Zhang L; He X; Yi X; Li Y; Yi X Front Chem; 2021; 9():765021. PubMed ID: 34746097 [TBL] [Abstract][Full Text] [Related]
8. Co-delivery of siBcl-2 and PTX with mitochondria-targeted functions to overcoming multidrug resistance. Zhang L; Cao X; Chen J; Dong Y; Chen W; Gao Y; Guo J; Huang H Int J Pharm; 2024 Apr; 654():123970. PubMed ID: 38447779 [TBL] [Abstract][Full Text] [Related]
9. Folate-PEG Conjugates of a Far-Red Light-Activatable Paclitaxel Prodrug to Improve Selectivity toward Folate Receptor-Positive Cancer Cells. Thapa P; Li M; Karki R; Bio M; Rajaputra P; Nkepang G; Woo S; You Y ACS Omega; 2017 Oct; 2(10):6349-6360. PubMed ID: 29104951 [TBL] [Abstract][Full Text] [Related]
10. PD-L1 monoclonal antibody-decorated nanoliposomes loaded with Paclitaxel and P-gp transport inhibitor for the synergistic chemotherapy against multidrug resistant gastric cancers. Yu J; Hu F; Zhu Q; Li X; Ren H; Fan S; Qian B; Zhai B; Yang D Nanoscale Res Lett; 2020 Mar; 15(1):59. PubMed ID: 32166458 [TBL] [Abstract][Full Text] [Related]
11. Mitochondrial Targeting and pH-Responsive Nanogels for Co-Delivery of Lonidamine and Paclitaxel to Conquer Drug Resistance. Chen E; Wang T; Zhang J; Zhou X; Niu Y; Liu F; Zhong Y; Huang D; Chen W Front Bioeng Biotechnol; 2021; 9():787320. PubMed ID: 34912792 [TBL] [Abstract][Full Text] [Related]
12. Catalase-Functionalized Iron Oxide Nanoparticles Reverse Hypoxia-Induced Chemotherapeutic Resistance. Yen TY; Stephen ZR; Lin G; Mu Q; Jeon M; Untoro S; Welsh P; Zhang M Adv Healthc Mater; 2019 Oct; 8(20):e1900826. PubMed ID: 31557421 [TBL] [Abstract][Full Text] [Related]
13. Reactive oxygen species-responsive polyprodrug micelles deliver cell cycle regulators for chemosensitization. Sun Y; Wu Q; Fu Q; Cong H; Shen Y; Yu B; Hu H Talanta; 2024 Jan; 267():125242. PubMed ID: 37801926 [TBL] [Abstract][Full Text] [Related]
14. Apoferritin-Cu(II) Nanoparticles Induce Oncosis in Multidrug-Resistant Colon Cancer Cells. Xiong K; Lin X; Kou J; Wei F; Shen J; Chen Y; Ji L; Chao H Adv Healthc Mater; 2024 Feb; 13(5):e2302564. PubMed ID: 38073257 [TBL] [Abstract][Full Text] [Related]
15. A Dual Bispecific Hydrolysis Peptide-Drug Conjugate Responsive to Micro-Acidic and Reduction Circumstance Promotes Antitumor Efficacy in Triple-Negative Breast Cancer. Tang T; Liu N; Wang L; Zuo K; Zhu X Chembiochem; 2024 Jul; ():e202400426. PubMed ID: 38965692 [TBL] [Abstract][Full Text] [Related]
16. A redox-responsive self-assembling COA-4-arm PEG prodrug nanosystem for dual drug delivery suppresses cancer metastasis and drug resistance by downregulating hsp90 expression. Zhou Y; Miao Y; Huang Q; Shi W; Xie J; Lin J; Huang P; Yue C; Qin Y; Yu X; Wang H; Qin L; Chen J Acta Pharm Sin B; 2023 Jul; 13(7):3153-3167. PubMed ID: 37521875 [TBL] [Abstract][Full Text] [Related]
17. Nanotechnology-based combination therapy for overcoming multidrug-resistant cancer. Zhang M; Liu E; Cui Y; Huang Y Cancer Biol Med; 2017 Aug; 14(3):212-227. PubMed ID: 28884039 [TBL] [Abstract][Full Text] [Related]
18. Retraction Note: Co-delivery of doxorubicin and SIS Wang S; Tan X; Zhou Q; Geng P; Wang J; Zou P; Deng A; Hu J Drug Deliv Transl Res; 2024 Jul; 14(7):2019. PubMed ID: 38051476 [No Abstract] [Full Text] [Related]
19. Enzyme-catalyzed synthesis of selenium-doped manganese phosphate for synergistic therapy of drug-resistant colorectal cancer. Pei M; Liu K; Qu X; Wang K; Chen Q; Zhang Y; Wang X; Wang Z; Li X; Chen F; Qin H; Zhang Y J Nanobiotechnology; 2023 Mar; 21(1):72. PubMed ID: 36859296 [TBL] [Abstract][Full Text] [Related]
20. Micelles as potential drug delivery systems for colorectal cancer treatment. Fatfat Z; Fatfat M; Gali-Muhtasib H World J Gastroenterol; 2022 Jul; 28(25):2867-2880. PubMed ID: 35978871 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]